Ocular Therapeutix (FRA:0OT) Ending Cash Position : €445.88 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix Ending Cash Position?

Ocular Therapeutix's Ending Cash Position for the quarter that ended in Mar. 2024 was €445.88 Mil.

Ocular Therapeutix's quarterly Ending Cash Position increased from Sep. 2023 (€105.24 Mil) to Dec. 2023 (€181.17 Mil) and increased from Dec. 2023 (€181.17 Mil) to Mar. 2024 (€445.88 Mil).

Ocular Therapeutix's annual Ending Cash Position declined from Dec. 2021 (€146.85 Mil) to Dec. 2022 (€98.24 Mil) but then increased from Dec. 2022 (€98.24 Mil) to Dec. 2023 (€181.17 Mil).

Ocular Therapeutix Ending Cash Position Historical Data

The historical data trend for Ocular Therapeutix's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix Ending Cash Position Chart

Ocular Therapeutix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

50.58

188.91

146.85

98.24

181.17

Ocular Therapeutix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															75.46	63.11	105.24	181.17	445.88

Ocular Therapeutix Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ocular Therapeutix's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	95.428	+	85.745
	=	181.17

Ocular Therapeutix's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	181.766	+	264.114
	=	445.88

Ocular Therapeutix Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocular Therapeutix (FRA:0OT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (FRA:0OT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

OCUL:USA 0OT:Germany

Address

24 Crosby Drive, Bedford, MA, USA, 01730

Website

https://www.ocutx.com

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix (FRA:0OT) Headlines

No Headlines